RESULTS

Opposite roles of Erk and p38 in cell migration
MAPKs have been linked to the regulation of cell migration 16, 17 . However, whether different MAPK isoforms have distinct roles in cell migration and the underlying mechanisms has remained unclear. We treated differentiated HL60 cells with specific inhibitors of MAPKs or knocked down the MAPKs by RNA-mediated interference (RNAi; Supplementary Fig. 1 ) and characterized migratory activity of these cells in fMLF concentration gradients. Whereas ~80% of control cells migrated up the fMLF gradient (100 nM; n = 109 cells) and reached the top (Fig. 1a,b , Supplementary Table 1 and Supplementary Video 1), only ~20% of the cells treated by RNAi for knockdown of p38α (the predominant isoform expressed in HL60 cells 22 ) or the p38 inhibitor SB203580 migrated through and reached the top (n = 147 cells; Fig. 1a,b, Supplementary Table 1 and Supplementary Video 2). The remaining cells were able to polarize and migrate initially in the attractant gradient but quickly lost directionality and 'wandered' aimlessly without net forward locomotion, thus ceasing directional migration. The chemotaxis index (CI; the ratio of net migration in the correct direction to total migration distance 8 ) was significantly lower in cells treated with RNAi of p38α or with SB203580 than in control cells (0.46 and 0.41 versus 0.72; P < 0.001, Fig. 1c ). We obtained similar results in a second chemotaxis assay, in an in vivo transmigration assay and by using human neutrophils ( Supplementary Figs. 2 and 3) .
To further demonstrate the regulatory effect of p38 on cell migration, we examined migratory activity in p38α-deficient neutrophils obtained from mice with conditional knockout of p38α (ref. 23 ). We found substantially less transmigration in vivo and chemotaxis in vitro by p38α-deficient neutrophils (Supplementary Fig. 4a-e ), consistent with our observations (described above) of cells treated with SB203580 or RNAi.
In contrast to results obtained by inhibition of p38, cells treated with the Erk inhibitor PD98059 or with RNAi of Erk showed more chemotaxis than did untreated control cells, with more than 95% of cells migrating through the entire gradient (n = 331 cells; Fig. 1a,b , Supplementary Table 1 and Supplementary Video 3). The CI of cells treated with RNAi of Erk or with PD98059 was significantly higher than that of untreated control cells (0.88 and 0.92 versus 0.72, P < 0.001; Fig. 1c ). We obtained similar results with U0126, another Erk inhibitor (Supplementary Fig. 4 ). However, inhibition of Jnk with SP600125 has little effect on cell migration (Fig. 1b,c) . Neither cell polarization, measured by actin polymerization, nor cell-migration speed, measured before cells lost net forward locomotion, were affected in cells in which p38 or Erk was inhibited ( Supplementary  Fig. 5 and Fig. 1d ). Thus, downregulation of p38 inhibited the directional migration of cells in an fMLF gradient, whereas inhibition of Erk enhanced cell chemotaxis, which suggested that these two MAPKs have opposing functions in neutrophil chemotaxis.
Concentration-dependent cell-activity switch
As high concentrations of chemoattractants are known to inhibit neutrophil orientation 24 , we next characterized the chemotactic activities of differentiated HL60 cells in various fMLF concentration gradients ( Fig. 2) . In gradients generated by a lower concentration of fMLF (50 nM and 100 nM), the majority of cells (>70%; n = 186) showed continuous directional migration up the gradient field ( Fig. 2a,b and Supplementary Table 1 ). In contrast, in gradients generated by a higher concentration of fMLF (500 nM and 1,000 nM), only ~10% of cells (n = 355) completed migration through the gradient ( Fig. 2a,b and Supplementary Table 1 ). As expected, the CI was significantly lower at fMLF gradients of higher concentration (0.38 and 0.27 for 500 nM and 1,000 nM, respectively; Fig. 2c ) than at fMLF gradients of lower concentration (0.66 and 0.72 for 50 nM and 100 nM, respectively; Fig. 2c ). We obtained similar results for neutrophil transmigration into the peritoneal cavity of wild-type mice ( Fig. 2e) , for human neutrophils (Supplementary Fig. 3 ) and with cells stimulated by uniform concentrations of fMLF (used for assessment of chemokinesis; Supplementary  Fig. 2b,d) . Thus, the migration of cells in response to higher-concentration fMLF gradients (such as 500 nM) was similar to that of cells treated with SB203580 or with RNAi of p38α in response to fMLF gradients of lower concentration (such as 100 nM).
To address whether p38 or Erk is involved in terminating directional cell migration, we next assessed the activation of both p38 and Erk at various concentrations of fMLF. We found that activation of p38 (measured by its phosphorylation) peaked at an fMLF concentration of 100 nM, then dropped considerably at concentrations of 500 and 1,000 nM (Fig. 3a) . The activation of Erk also peaked at 100 nM but plateaued as fMLF concentration was increased further (Fig. 3b) . In the activation assays described above, we stimulated cells for 2 min, as phosphorylation of p38 and Erk peaked at 2 min for each concentration of fMLF ( Supplementary Fig. 5c ). We obtained similar results with human neutrophils (Supplementary Fig. 6 ). 
A r t i c l e s
To test whether the lower p38 activity and sustained Erk activity were responsible for the impaired chemotaxis at high concentrations of fMLF, we treated cells with either anisomycin, which activates p38 (ref. 25 ; Supplementary Fig. 1 ), or PD98059, which inhibits Erk, and assessed their chemotactic migration in the gradient at 500 nM. Notably, unlike the untreated control cells, most of which ceased directional migration in the middle of the gradient field, ~70% of p38-activated cells (n = 95) migrated through the field (Fig. 3c,d and Supplementary Table 1 ). The CI of those cells was significantly higher than that of untreated control cells in a 500-nM gradient (0.76 versus 0.37; P < 0.001) but was similar to the CI of control cells migrating in a gradient of 100 nM fMLF ( Figs. 3e and 1c) . We obtained similar results by inhibiting Erk with PD98059 ( Fig. 3c-e ). These observations indicated that p38 counteracted the stop signal during cell chemotaxis, whereas Erk enhanced it.
MAPKs regulate FPR1 internalization in different ways
We next explored which signals for the cessation of directional cell migration might be induced by high concentrations of fMLF. Attractants not only activate the appropriate trimeric G proteins but also promote receptor internalization and thus prevent the receptor from activating G proteins [11] [12] [13] . We assessed whether the impaired cell migration at high concentrations of fMLF resulted from less receptor availability as a result of receptor internalization. We found that receptor internalization, measured in HL60 cells or human neutrophils by fluorescence-labeled fMLF, increased along with increasing fMLF concentrations ( Fig. 2f and Supplementary Fig. 6c ), consistent with a published report 24 . Further analysis of time-response curves of the receptor internalization at fMLF concentrations of 100 nM and 500 nM also confirmed the observations noted above (Supplementary Fig. 5d ).
Furthermore, to prevent receptor internalization, we used FPR1-∆ST, a mutant of FPR1 with substitution of alanine or glycine for all carboxy-terminal serine and threonine residues 15 . As expected, cells expressing wild-type FPR1 quickly arrested at a uniform concentration of 500 nM fMLF ( Fig. 4a, top) . The majority of cells (~70%; n = 33) lost net locomotion during the 15-minute recording period ( Fig. 4b, left) . In contrast, only ~13% of cells expressing FPR1-∆ST (n = 69) arrested during the same recording period ( Fig. 4b, right ). Those cells also had negligible receptor internalization (Fig. 4a, bottom) . On the basis of the trajectories of the two groups of cells ( Fig. 4b) , the mean migration distance of the wild-type cells was significantly shorter than that of the cells expressing FPR1-∆ST (17.9 µm versus 33.4 µm (P < 0.01); Fig. 4c ). Thus, higher concentrations of fMLF enhanced receptor internalization and promoted the cessation of neutrophil migration. npg A r t i c l e s Prevention of receptor internalization restored cell migration at high concentrations of fMLF, which indicated that more receptor internalization at high concentrations of chemoattractant acted as an essential stop signal for chemotactic neutrophils. We next determined whether p38 and Erk have opposing effects on receptor internalization. To visualize receptor internalization, we expressed a yellow fluorescent protein (YFP)-tagged FPR1 in HEK293 human embryonic kidney cells, which lack endogenous FPR1. Receptor internalization was evident within 15 min of fMLF stimulation in untreated control cells but was present as early as 3 min after fMLF stimulation in SB203580-treated cells (Fig. 5a) .
In contrast, much of the FPR1-YFP signal remained at the plasma membrane in PD98059-treated cells after 15 min ( Fig. 5a) , which indicated that there was little if any receptor internalization. We obtained similar results with HL60 cells (Fig. 5b,c) and human neutrophils ( Supplementary Fig. 6e,f) . Together, these results showed that Erk and p38 had opposite effects on FPR1 internalization.
GRK2 mediates the stop signal for chemotaxis GRK2 is known to promote FPR1 internalization through phosphorylation 13 . To determine whether GRK2 mediates the stop signal during chemotaxis, we knocked down GRK2 in HL60 cells by RNAi ( Supplementary Fig. 1 ) and measured migration of these cells in the presence or absence of SB203580. As expected, inhibition of p38 resulted in less directional migration of untreated control cells in an fMLF gradient of 100 nM (Fig. 6a-c and Supplementary Table 1 ). Knockdown of GRK2 reversed this effect and restored cell migration ( Fig. 6a-c and Supplementary Table 1 ), which suggested that the SB203580-induced cell arrest was mediated through GRK2. That finding led us to test whether p38 and Erk affected GRK2 function. We found more association of GRK2 with the membrane after fMLF stimulation in untreated control cells ( Fig. 6d,e ). Treatment of the cells with SB203580 further increased the association of GRK2 with the membrane in basal and stimulated states ( Fig. 6d,e ), which indicated that p38 antagonized recruitment of GRK2 to the membrane. We obtained similar results with human neutrophils ( Supplementary  Fig. 7) . In contrast, PD98059 prevented the recruitment of GRK2 to the membrane (Fig. 6f,g and Supplementary Fig. 7) , which suggested that Erk enhanced the activity of GRK2.
Blockade of GRK2 function by p38 acting as a GRK
Erk has been shown to prevent GRK2 degradation 26, 27 . We observed a similar effect in HL60 cells treated with RNAi of Erk, which had much less abundance of GRK2 before and after fMLF stimulation npg A r t i c l e s ( Supplementary Fig. 8a) . However, the mechanism by which p38 regulates GRK2 remained unclear. By immunostaining, we examined subcellular localization of p38 and FPR1 in HL60 cells. We found phosphorylated p38 in the pseudopods of polarized cells, whereas total p38 was distributed more uniformly (Fig. 7a) . FPR1 localized mainly to the cell membrane at both the leading and trailing edges (Fig. 7b) . Thus, phosphorylated p38 might interact with FPR1 in pseudopods. We assessed that possibility by immunoprecipitation of p38 with FPR1 and found that the binding of p38 to FPR1 was greater after fMLF stimulation and was inhibited by SB203580 ( Fig. 7c) . We obtained similar results with human neutrophils (Supplementary Fig. 7) . In contrast, phosphorylated Erk was distributed uniformly and we detected no interaction between Erk and FPR1 (Supplementary Fig. 8b,c) . Because p38 phosphorylates serine and threonine residues 28 and there are 19 serine and/or threonine residues in the intracellular domains of FPR1, including 11 in the carboxyl tail (of a total of a SB+ GRK2i npg A r t i c l e s 350 amino acids), we investigated whether p38 phosphorylates FPR1. We individually expressed the three intracellular loops and the carboxy-terminal tail of FPR1 as glutathione S-transferase-tagged proteins and purified the proteins for in vitro phosphorylation assays. After incubation with purified phosphorylated p38, only the carboxyterminal tail was phosphorylated (Fig. 7d) ; this phosphorylation was inhibited by SB203580 (data not shown). To map the phosphorylation site(s), we generated the following two mutants: in one, we replaced the six serine and/or threonine residues among amino acids 319-332 of the carboxy-terminal tail with alanine or glycine (Fig. 7e) ; in the other, we replaced the five serine and/or threonine residues among amino acids 334-342 with alanine or glycine (Fig. 7e) . We found that p38 phosphorylated the former but not the latter (Fig. 7d) . We next replaced each of the five serine and/or threonine residues among amino acids 334-342 individually and identified Ser342 (Fig. 7d) as the only phosphorylation site for p38. Notably, Ser342 is not one of the GRK2 phosphorylation sites identified before by site mutagenesis 13 (Fig. 7e) . We next determined whether p38 prevented binding of GRK2 to FPR1. In untreated control cells, fMLF stimulation resulted in more binding of FPR1 to GRK2. This binding was even greater in cells in which p38 was knocked down (Fig. 7f) . To determine whether phosphorylation of FPR1 by p38 prevents the binding of GRK2, we generated constructs of FLAG-tagged wild-type FPR1 and the following two FPR1 mutants: FPR1-S342A, which prevents p38 phosphorylation, and FPR1-S342D, which mimics phosphorylation at this site. We found that p38 bound to wild-type FPR1 and the two mutants equally well (Fig. 7g) . In contrast, GRK2 showed much less binding to FPR1-S342D than to wild-type or FPR1-S342A (Fig. 7g) . Furthermore, HL60 cells expressing FPR1-S342D migrated farther in an fMLF gradient of high concentration (500 nM) than did cells expressing wild-type FPR1 (Fig. 7h,i) . Together these results indicated that p38 phosphorylation at Ser342 prevented the interaction of GRK2 with FPR1. Thus, p38 functions as a noncanonical GRK that counteracts the function of GRK2.
Different regulation by G proteins of Erk versus p38
As shown above, Erk and p38 had opposite roles in cell migration, which raised the possibility that Erk and p38 antagonize each other. However, we found that p38 activation was not altered in cells with RNAi of Erk, and Erk activation was not altered in cells with RNAi of p38 (Fig. 8a,b) , which indicated p38 and Erk were independently regulated. That conclusion was further supported by finding that p38 and Erk had distinct activation patterns in response to increasing concentrations of fMLF ( Fig. 3 and Supplementary Fig. 6 ). Whereas the activation of Erk plateaued, the activation curve of p38 was bellshaped. To determine how regulation of Erk differed from that of p38, we assessed whether various heterotrimeric G proteins activated by FPRs mediated activation of Erk and p38. Inactivation of Gi by pertussis toxin abolished p38 activation, but only partially inhibited Erk activity (~70% inhibition, Fig. 8c,d) , which indicated that some activation of Erk was independent of Gi. Because Erk and p38 showed different activation patterns with increasing fMLF concentrations, we assessed the concentration-dependent activation of Erk and p38 in the presence of pertussis toxin. At all concentrations tested, pertussis toxin blocked p38 activation but only partially inhibited Erk activation (Supplementary Fig. 9a ). We used RNAi to screen other G proteins that might mediate Erk activation (Supplementary Fig. 1 ). We found that knockdown of Gq resulted in significantly less fMLF-induced activation of Erk but did not affect p38 activation (Fig. 8e,f) .
We further determined whether MAPK phosphatase had a role in the regulation of Erk and p38. We first tested WIP1, a MAPK phosphatase that belongs to the protein phosphatase family 2C and is specific for p38 but not Erk 29 . Cells treated with the protein phosphatase 2 inhibitor okadaic acid or with knockdown of WIP1 by RNAi (Supplementary Fig. 1 ) showed a delayed decrease in phosphorylated p38 (Supplementary Fig. 9) ; however, neither treatment altered the bell-shaped activation curve of p38 (Supplementary Fig. 9 ). We next tested two dual-specificity MAPK phosphatases: MKP1 and MKP5, which dephosphorylate both p38 and Erk 30 . Knockout of the gene encoding MKP1 or MKP5 in mouse neutrophils resulted in a greater abundance of phosphorylated p38 after stimulation with chemoattractants but did not affect the bell-shaped activation curve of p38 (data not shown). Thus, these phosphatases did not seem to be required for the activation of Erk or p38 under our experimental conditions. It is possible, however, that heterotrimeric G proteins activated differently by one or more formyl peptide receptors could be responsible for the observed differences in the activation of Erk and p38.
DISCUSSION
Understanding how chemotaxis is dynamically and precisely regulated is of great importance, given its vital roles in inflammatory cell infiltration, lymphocyte homing, embryonic development, axon guidance and tumor invasion. In addition to triggering polarization and directional sensing, which are important for initiation of neutrophil chemotaxis, chemoattractant stimulation elicits a distinct stop mechanism that negatively regulates directional cell migration and npg brings chemotactic cells to a state similar to that of unstimulated cells. This mechanism is represented by the incremental amount of membrane association of GRK2 and internalization of FPR1. Our results have demonstrated that, to achieve efficient and precise directional migration, Erk and p38 exerted opposite effects on the stop mechanism. Inhibition of p38 activity enhanced the stop signal and arrested migrating cells, whereas enhancement of the activity of p38 or inhibition of the activity of Erk seemed to overcome the stop signal and ensured directed cell migration, even at concentrations of fMLF that would normally induce termination of cell chemotaxis. Our results have shown that Erk-GRK2 functioned as a mechanism for the termination of chemotaxis and have demonstrated that constant suppression (by p38) of the stop mechanism was required for sustained chemotaxis and for migrating cells to reach their final destinations.
Although p38 has an important role in neutrophil chemotaxis [18] [19] [20] [21] , the underlying mechanisms have not been clear. Here we have demonstrated a previously unknown function of p38 as a GRK that phosphorylates a chemoattractant receptor and blocks the function of the classical GRK2. Different phosphorylation patterns of G protein-coupled receptors may 'instruct' different downstream partners to achieve different functions 31 . Our observations of FPR1 supported that proposal. We found that p38 and GRK2 phosphorylated the carboxy-terminal tail of FPR1 at distinct nonoverlapping sites. The phosphorylation of Ser342 in FPR1 by p38 prevented the receptor from interacting with GRK2 and thereby blocked the GRK2-mediated stop signal and ensured sustained cell migration. Thus, different phosphorylation patterns on FPR1 by p38 and GRK2 achieved opposite functions downstream of the receptor, which indicated the subtlety of the regulation of neutrophil migration by p38.
Studies have reported negligible chemotaxis deficiencies in cells expressing receptors that cannot be desensitized, which suggests that receptor desensitization is not required for chemotaxis 15 . Our findings, however, have indicated that GRK2-mediated receptor internalization and desensitization had an essential role in regulating cell migration and was responsible for the termination of cell migration at high concentrations of attractant. Thus, it was the enhancement of receptor desensitization, not its inhibition, that blocked neutrophil chemotaxis. Moreover, our findings have shown that sufficient protection of the receptor from desensitization was required for sustained cell migration and that overprotection of receptor from desensitization led to nonstop migration. Therefore, the precise navigation of migrating cells required a balance between the acceleration and deceleration of receptor desensitization, which were mediated by GRK2 and p38, respectively. In other words, signals that control receptor desensitization have a central role in determining the final destination of migrating neutrophils.
Our results have shown that different heterotrimeric G protein signals downstream of the formyl peptide receptor were responsible for the regulation of Erk and p38. Activation of p38 was dependent on Gi, whereas Erk was activated by both Gi and Gq signals. In neutrophils, there are two formyl peptide receptor isoforms: FPR1 is the high-affinity receptor for fMLF (with a dissociation constant of ~10 nM) and activates Gi; FPR2 is the low-affinity receptor for fMLF (dissociation constant ~1 µm) and activates Gq 32 . Thus, at lower concentrations of fMLF, FPR1 activated Gi, which led to the activation of both p38 and Erk; when fMLF concentration increased, FPR2 was activated, thus activating Gq, which was responsible for sustained Erk activation. At the same time, p38 activity decreased as more FPR1 was internalized under exposure to high concentrations of fMLF. We suggest that the different regulatory functions of these two MAPKs provide bidirectional control of GRK2 function at different stages of directional cell migration, thus allowing migrating cells to accurately reach their destinations.
To reach sites of infection or inflammation, circulating neutrophils must first attach to the endothelial cells lining the blood vessels, then transmigrate into tissue. The mechanisms responsible for the initial arrest of neutrophils in the endothelium are mediated mainly by the interaction of β 2 integrins with their endothelial ligand, ICAM-1 (refs. [33] [34] [35] . Whether this initial arrest mechanism also has a role in terminating neutrophil migration remains unclear. Likewise, it is unknown whether MAPKs or GRKs terminate directional cell migration by regulating integrin activation. Animals such as fruit flies have a concentration-dependent activity switch mediated by differences in the regulation of neural circuits in response to odor stimulation 36 . Such a concentration-dependent switch can also be observed at the cellular level as a bell-shaped dose-response curve during cell migration. Directed cell migration initially increases in response to an increase in attractant concentration, but peaks and then gradually decreases as attractant concentration is further increased. Therefore, studies at the cellular level may provide further molecular mechanisms and insights for understanding activity switches in more complex organisms.
Our results suggest a model for neutrophil migration in which the dynamic balance of GRK2 and two MAPKs regulates go and stop activity at the receptor level. Our model indicates a mechanism for a concentration-dependent switch for the cell to continue or halt its movement during directional cell migration. The model of stop and go signals provides the opportunity for pharmacological intervention in one or more of the specific pathway(s). Such an intervention would enable appropriate infiltration of phagocytes into inflammatory sites while minimizing neutrophil-mediated tissue injury.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
